Ryota Asahina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ryota Asahina has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Sadatoshi Maeda
The United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan
7 shared publications Hidetaka Nishida
Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan
5 shared publicationsHiroaki Kamishina
Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan
5 shared publications- Kenji Kabashima
Department of Dermatology Kyoto University Graduate School of Medicine Kyoto Japan
5 shared publications - Gyohei Egawa
Department of Dermatology Kagoshima University Graduate School of Medical and Dental Sciences Kagoshima Japan
3 shared publications - Saeko Nakajima
Department of Dermatology Kyoto University Graduate School of Medicine Kyoto Japan
3 shared publications
Latest Publications
- Open Access
Initial OX40 – OX40L Signaling Promotes a Skin‐Resident Memory T‐Cell Reservoir in Atopic Dermatitis
- 1 April 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (4) , 1233-1237.e1
Cutaneous Liver X Receptor Activation Prevents the Formation of Imiquimod-Induced Psoriatic Dermatitis
- 1 April 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (4) , 1233-1237.e1
Cutaneous Liver X Receptor Activation Prevents the Formation of Imiquimod-Induced Psoriatic Dermatitis
- 25 March 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (10) , 2827-2831.e3
In Vivo Imaging of CD8+ T-Cell‒Mediated Keratinocyte Apoptosis in Graft-Versus-Host Disease‒Like Dermatitis in Involucrin Membrane-Bound Ovalbumin Mice
- 25 March 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (10) , 2827-2831.e3
In Vivo Imaging of CD8+ T-Cell‒Mediated Keratinocyte Apoptosis in Graft-Versus-Host Disease‒Like Dermatitis in Involucrin Membrane-Bound Ovalbumin Mice
- Open Access
- 18 November 2021
- Published by Wiley in Veterinary Dermatology
- Vol. 32 (6) , 605-e161
Narrow‐band ultraviolet B therapy attenuates cutaneous T‐cell responses in hapten‐induced, experimental contact dermatitis in beagles
Background: In human medicine, narrow‐band ultraviolet B (NB‐UVB) phototherapy has been used to treat various T‐cell‐mediated skin diseases. However, the effect of NB‐UVB on inflamed canine skin remains uncertain.Objectives: To investigate the effect of NB‐UVB phototherapy on the skin of dogs with hapten‐induced contact dermatitis.Animals: Seven healthy beagles without skin problems.Methods and materials: Dogs were irradiated with varying doses of NB‐UVB to determine the minimal erythema dose (MED). After determining the MEDs of six dogs (excluding one of the seven whose skin did not show a visible reaction), we investigated the effect of NB‐UVB on their inflamed skin by topically applying 2,4‐dinitrochlorobenzene (DNCB), which causes type 1 helper T cell (Th1)‐ and cytotoxic T‐cell (Tc)1‐induced skin inflammation. We then irradiated the skin with NB‐UVB. We analysed the treated skin samples via histopathological and immunohistochemical methods, and TdT‐mediated dUTP nick‐end labelling (TUNEL) to demonstrate apoptotic cells. We also analysed the cytokine gene transcription via real‐time quantitative reverse transcription PCR.Results: The NB‐UVB MEDs caused mild inflammatory changes yet no severe epidermal exfoliations in the irradiated skin. In DNCB‐treated skin irradiated by the NB‐UVB MEDs, TUNEL‐positive dermal apoptotic cells were increased significantly compared with those of DNCB‐treated, nonirradiated skin. INF‐γ and TNF‐α transcription levels in DNCB‐treated, irradiated skin were significantly lower than those in the DNCB‐treated, nonirradiated skin.Conclusion and clinical relevance: Phototherapy using NB‐UVB MEDs attenuated cutaneous Th1 and Tc1 cytokine responses with minimal skin damage in a canine model of hapten‐induced contact dermatitis.
- 18 November 2021
- Published by Wiley in Veterinary Dermatology
- Vol. 32 (6) , 605-e161
Open AccessNarrow‐band ultraviolet B therapy attenuates cutaneous T‐cell responses in hapten‐induced, experimental contact dermatitis in beagles
Background: In human medicine, narrow‐band ultraviolet B (NB‐UVB) phototherapy has been used to treat various T‐cell‐mediated skin diseases. However, the effect of NB‐UVB on inflamed canine skin remains uncertain.Objectives: To investigate the effect of NB‐UVB phototherapy on the skin of dogs with hapten‐induced contact dermatitis.Animals: Seven healthy beagles without skin problems.Methods and materials: Dogs were irradiated with varying doses of NB‐UVB to determine the minimal erythema dose (MED). After determining the MEDs of six dogs (excluding one of the seven whose skin did not show a visible reaction), we investigated the effect of NB‐UVB on their inflamed skin by topically applying 2,4‐dinitrochlorobenzene (DNCB), which causes type 1 helper T cell (Th1)‐ and cytotoxic T‐cell (Tc)1‐induced skin inflammation. We then irradiated the skin with NB‐UVB. We analysed the treated skin samples via histopathological and immunohistochemical methods, and TdT‐mediated dUTP nick‐end labelling (TUNEL) to demonstrate apoptotic cells. We also analysed the cytokine gene transcription via real‐time quantitative reverse transcription PCR.Results: The NB‐UVB MEDs caused mild inflammatory changes yet no severe epidermal exfoliations in the irradiated skin. In DNCB‐treated skin irradiated by the NB‐UVB MEDs, TUNEL‐positive dermal apoptotic cells were increased significantly compared with those of DNCB‐treated, nonirradiated skin. INF‐γ and TNF‐α transcription levels in DNCB‐treated, irradiated skin were significantly lower than those in the DNCB‐treated, nonirradiated skin.Conclusion and clinical relevance: Phototherapy using NB‐UVB MEDs attenuated cutaneous Th1 and Tc1 cytokine responses with minimal skin damage in a canine model of hapten‐induced contact dermatitis.
- Open Access
- 17 September 2020
- Published by Wiley in Veterinary Dermatology
- Vol. 31 (6) , 446-455
Serum canine thymus and activation‐regulated chemokine (TARC/CCL17) concentrations correlate with disease severity and therapeutic responses in dogs with atopic dermatitis
Résumé: Contexte: La TARC/CCL17 (thymus and activation‐regulated chemokine) a été impliquée dans la pathogénie de la dermatite atopique canine (cAD). Les concentrations sériques de TARC sont un biomarqueur fiable chez l’homme atopique ; cependant, leur potentiel en tant que biomarqueur pour cAD n’a pas été étudié.Hypothèses/Objectifs: Etudier si les concentrations sériques de TARC corrèlent avec la sévérité de la maladie et les réponses thérapeutiques pour cAD.Sujets: Trente – neuf chiens avec cAD et 42 chiens sains ont été inclus.Matériels et méthodes: Les concentrations sériques en TARC chez les chiens avec cAD et les chiens sains ont été mesurées par ELISA avec anticorps anti‐TARC canin. La sévérité clinique de cAD a été notée par CADESI‐04 (Canine Atopic Dermatitis Extent and Severity Index, 4th iteration). Les concentrations de TARC sériques ont été comparées entre les chiens avec cAD et les chiens sains contrôles, et leur relation avec CADESI‐04 a été étudiée. Les concentrations sériques de TARC ont aussi été mesurées chez 20 chiens avec cAD traités par prednisolone ou oclacitinib pendant quatre semaines.Résultats: Les concentrations sériques de TARC étaient significativement plus élevées chez les chiens avec cAD que chez les chiens sains (P < 0.001). Chez les chiens avec cAD, les concentrations sériques de TARC corrélaient avec les scores de CADESI‐04 (ρ = 0.457, P< 0.01). En outre, les concentrations sériques de TARC diminuaient significativement chez les chiens traités avec atténuation des signes cliniques (P < 0.001). Les changements de concentrations sériques de TARC avant et après traitement corrélaient avec ceux des scores CADESI‐04 (ρ = 0.746, P < 0.001).Conclusions et importance clinique: Les concentrations sériques de TARC ont le potentiel d’être un outil clinique et de recherche pour l’évaluation objective de l’intensité de la maladie et de la réponse thérapeutique de la CAD.
- 17 September 2020
- Published by Wiley in Veterinary Dermatology
- Vol. 31 (6) , 446-455
Open AccessSerum canine thymus and activation‐regulated chemokine (TARC/CCL17) concentrations correlate with disease severity and therapeutic responses in dogs with atopic dermatitis
Résumé: Contexte: La TARC/CCL17 (thymus and activation‐regulated chemokine) a été impliquée dans la pathogénie de la dermatite atopique canine (cAD). Les concentrations sériques de TARC sont un biomarqueur fiable chez l’homme atopique ; cependant, leur potentiel en tant que biomarqueur pour cAD n’a pas été étudié.Hypothèses/Objectifs: Etudier si les concentrations sériques de TARC corrèlent avec la sévérité de la maladie et les réponses thérapeutiques pour cAD.Sujets: Trente – neuf chiens avec cAD et 42 chiens sains ont été inclus.Matériels et méthodes: Les concentrations sériques en TARC chez les chiens avec cAD et les chiens sains ont été mesurées par ELISA avec anticorps anti‐TARC canin. La sévérité clinique de cAD a été notée par CADESI‐04 (Canine Atopic Dermatitis Extent and Severity Index, 4th iteration). Les concentrations de TARC sériques ont été comparées entre les chiens avec cAD et les chiens sains contrôles, et leur relation avec CADESI‐04 a été étudiée. Les concentrations sériques de TARC ont aussi été mesurées chez 20 chiens avec cAD traités par prednisolone ou oclacitinib pendant quatre semaines.Résultats: Les concentrations sériques de TARC étaient significativement plus élevées chez les chiens avec cAD que chez les chiens sains (P < 0.001). Chez les chiens avec cAD, les concentrations sériques de TARC corrélaient avec les scores de CADESI‐04 (ρ = 0.457, P< 0.01). En outre, les concentrations sériques de TARC diminuaient significativement chez les chiens traités avec atténuation des signes cliniques (P < 0.001). Les changements de concentrations sériques de TARC avant et après traitement corrélaient avec ceux des scores CADESI‐04 (ρ = 0.746, P < 0.001).Conclusions et importance clinique: Les concentrations sériques de TARC ont le potentiel d’être un outil clinique et de recherche pour l’évaluation objective de l’intensité de la maladie et de la réponse thérapeutique de la CAD.
- 1 March 2019
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 209, 17-21
Th17 cells increase during maturation in peripheral blood of healthy dogs
- 1 March 2019
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 209, 17-21
Th17 cells increase during maturation in peripheral blood of healthy dogs
- 30 August 2018
- Published by Wiley in Veterinary Dermatology
- Vol. 29 (6) , 517-+
Phenotypic analysis of mice xenografted with canine epitheliotropic cutaneous T‐cell lymphoma cells
Background: In canine epitheliotropic cutaneous T‐cell lymphoma (ECTCL), neoplastic cells cause skin lesions and potentially metastasize to lymph nodes, blood and other organs. Murine models are potentially valuable for elucidating the molecular mechanisms responsible for regulation of ECTCL cell migration.Hypothesis/Objectives: To describe a phenotype of mice xenografted with canine ECTCL cells (EO‐1 cells).Animals: Four NOD.CB17‐Prkdcscid/J (NOD SCID) mice were used.Methods and materials: EO‐1 cells were subcutaneously xenografted into NOD SCID mice. After four weeks, the development of tumour lesions in skin and other organs was investigated.Results: Mice developed skin lesions with metastasis to the lymph nodes, spleen, lung, blood and liver.Conclusions and clinical importance: Mice xenografted with EO‐1 cells may be useful for studying the pathogenesis of canine ECTCL.
- 30 August 2018
- Published by Wiley in Veterinary Dermatology
- Vol. 29 (6) , 517-+
Phenotypic analysis of mice xenografted with canine epitheliotropic cutaneous T‐cell lymphoma cells
Background: In canine epitheliotropic cutaneous T‐cell lymphoma (ECTCL), neoplastic cells cause skin lesions and potentially metastasize to lymph nodes, blood and other organs. Murine models are potentially valuable for elucidating the molecular mechanisms responsible for regulation of ECTCL cell migration.Hypothesis/Objectives: To describe a phenotype of mice xenografted with canine ECTCL cells (EO‐1 cells).Animals: Four NOD.CB17‐Prkdcscid/J (NOD SCID) mice were used.Methods and materials: EO‐1 cells were subcutaneously xenografted into NOD SCID mice. After four weeks, the development of tumour lesions in skin and other organs was investigated.Results: Mice developed skin lesions with metastasis to the lymph nodes, spleen, lung, blood and liver.Conclusions and clinical importance: Mice xenografted with EO‐1 cells may be useful for studying the pathogenesis of canine ECTCL.
- 21 May 2018
- Published by Wiley in Veterinary Dermatology
- Vol. 29 (4) , 288-+
Expression of ZO‐1 and claudin‐1 in a 3D epidermal equivalent using canine progenitor epidermal keratinocytes
Background: Previous studies indicate that tight junctions are involved in the pathogenesis of canine atopic dermatitis (cAD). An in vitro skin model is needed to elucidate the specific role of tight junctions in cAD. A 3D epidermal equivalent model using canine progenitor epidermal keratinocytes (CPEK) has been established; the expression of tight junctions within this model is uncharacterized.Hypothesis/Objectives: To investigate the expression of tight junctions in the 3D epidermal equivalent.Animals: Two normal laboratory beagle dogs served as donors of full‐thickness skin biopsy samples for comparison to the in vitro model.Methods: Immunohistochemical techniques were employed to investigate the expression of tight junctions including zonula occludens (ZO)‐1 and claudin‐1 in normal canine skin, and in the CPEK 3D epidermal equivalent.Results: Results demonstrated the expression of ZO‐1 and claudin‐1 in the CPEK 3D epidermal equivalent, with staining patterns that were similar to those in normal canine skin.Conclusions and clinical importance: The CPEK 3D epidermal equivalent has the potential to be a suitable in vitro research tool for clarifying the specific role of tight junctions in cAD.
- 21 May 2018
- Published by Wiley in Veterinary Dermatology
- Vol. 29 (4) , 288-+
Expression of ZO‐1 and claudin‐1 in a 3D epidermal equivalent using canine progenitor epidermal keratinocytes
Background: Previous studies indicate that tight junctions are involved in the pathogenesis of canine atopic dermatitis (cAD). An in vitro skin model is needed to elucidate the specific role of tight junctions in cAD. A 3D epidermal equivalent model using canine progenitor epidermal keratinocytes (CPEK) has been established; the expression of tight junctions within this model is uncharacterized.Hypothesis/Objectives: To investigate the expression of tight junctions in the 3D epidermal equivalent.Animals: Two normal laboratory beagle dogs served as donors of full‐thickness skin biopsy samples for comparison to the in vitro model.Methods: Immunohistochemical techniques were employed to investigate the expression of tight junctions including zonula occludens (ZO)‐1 and claudin‐1 in normal canine skin, and in the CPEK 3D epidermal equivalent.Results: Results demonstrated the expression of ZO‐1 and claudin‐1 in the CPEK 3D epidermal equivalent, with staining patterns that were similar to those in normal canine skin.Conclusions and clinical importance: The CPEK 3D epidermal equivalent has the potential to be a suitable in vitro research tool for clarifying the specific role of tight junctions in cAD.